 |
市場調査レポート
体外毒性検査市場規模、シェア、動向分析：技術別、手法別（セルラーアッセイ、バイオケミカルアッセイ、インシリカ、Ex-vivo）、用途別、エンドユース別、地域別動向、セグメント予測In-vitro Toxicology Testing Market Size, Share & Trends Analysis Report By Technology (Cell Culture, High Throughput), By Method, By Application, By End Use, By Region, And Segment Forecasts, 2020 - 2027 |
||||||
| 発行 | Grand View Research, Inc. | 商品コード | 656141 | ||||
| 出版日 | ページ情報 | 英文 100 Pages 納期: 2-3営業日 |
|||||
| 価格 |
|
||||||
| 体外毒性検査市場規模、シェア、動向分析：技術別、手法別（セルラーアッセイ、バイオケミカルアッセイ、インシリカ、Ex-vivo）、用途別、エンドユース別、地域別動向、セグメント予測 In-vitro Toxicology Testing Market Size, Share & Trends Analysis Report By Technology (Cell Culture, High Throughput), By Method, By Application, By End Use, By Region, And Segment Forecasts, 2020 - 2027 | ||
| 出版日: 2020年02月13日 | ページ情報: 英文 100 Pages |
|
当レポートでは、世界の体外毒性検査市場について調査し、市場の現状と成長予測、技術別、手法別、用途別、エンドユース別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。
List of Figure
FIG. 1 Market segmentation & scope
FIG. 2 Market summary (USD Million)
FIG. 3 Market research process
FIG. 4 Information procurement
FIG. 5 Primary research pattern
FIG. 6 Market research approaches
FIG. 7 Value chain based sizing & forecasting
FIG. 8 QFD modelling for market share assessment
FIG. 9 Industry pyramid analysis
FIG. 10 Penetration & growth prospect mapping for application, 2019
FIG. 11 Market trends & outlook
FIG. 12 Market driver relevance analysis (Current & future impact)
FIG. 13 Various factors that are driving trend of non-animal technologies
FIG. 14 Market restraint relevance analysis (Current & future impact)
FIG. 15 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 16 Porter's Five Forces Analysis
FIG. 17 In-vitro toxicology testing market: Technology outlook key takeaways
FIG. 18 In-vitro toxicology testing market: Technology movement analysis
FIG. 19 Global cell culture technology market, by revenue 2016 - 2027 (USD Million)
FIG. 20 Global high-throughput technology market, by revenue 2016 - 2027 (USD Million)
FIG. 21 Global molecular imaging market, by revenue 2016 - 2027 (USD Million)
FIG. 22 Global OMICS technology market, by revenue 2016 - 2027 (USD Million)
FIG. 23 In-vitro toxicology testing market: Method outlook key takeaways
FIG. 24 In-vitro toxicology testing market: Method movement analysis
FIG. 25 Global cellular assays market for in-vitro toxicology testing, 2016 - 2027 (USD Million)
FIG. 26 Global biochemical assays market for in-vitro toxicology testing, 2016 - 2027 (USD Million)
FIG. 27 Global in silico assays market for in-vitro toxicology testing, 2016 - 2027 (USD Million)
FIG. 28 Global ex vivo assays market for in-vitro toxicology testing, 2016 - 2027 (USD Million)
FIG. 29 In-vitro toxicology testing market: Application outlook key takeaways
FIG. 30 In-vitro toxicology testing market: Application movement analysis
FIG. 31 Global systemic toxicology market, 2016 - 2027 (USD Million)
FIG. 32 Global dermal toxicology market, 2016 - 2027 (USD Million)
FIG. 33 Global endocrine disruption market, 2016 - 2027 (USD Million)
FIG. 34 Global ocular toxicity market, 2016 - 2027 (USD Million)
FIG. 35 Global other applications market, 2016 - 2027 (USD Million)
FIG. 36 In-vitro toxicology testing market: End-use outlook key takeaways
FIG. 37 In-vitro toxicology testing market: End-use movement analysis
FIG. 38 Global pharmaceutical industry market, 2016 - 2027 (USD Million)
FIG. 39 Global cosmetics & household products market, 2016 - 2027 (USD Million)
FIG. 40 Global diagnostics market, 2016 - 2027 (USD Million)
FIG. 41 Global chemical industry market, 2016 - 2027 (USD Million)
FIG. 42 Global food industry market, 2016 - 2027 (USD Million)
FIG. 43 Regional market place: Key takeaways
FIG. 44 In-vitro toxicology testing market regional outlook, 2019 & 2027
FIG. 45 North America in-vitro toxicology testing market, 2016 - 2027 (USD Million)
FIG. 46 U.S. in-vitro toxicology testing market, 2016 - 2027 (USD Million)
FIG. 47 Canada in-vitro toxicology testing market, 2016 - 2027 (USD Million)
FIG. 48 Europe in-vitro toxicology testing market, 2016 - 2027 (USD Million)
FIG. 49 Germany in-vitro toxicology testing market, 2016 - 2027 (USD Million)
FIG. 50 U.K. in-vitro toxicology testing market, 2016 - 2027 (USD Million)
FIG. 51 Asia Pacific in-vitro toxicology testing market, 2016 - 2027 (USD Million)
FIG. 52 China in-vitro toxicology testing market, 2016 - 2027 (USD Million)
FIG. 53 Japan in-vitro toxicology testing market, 2016 - 2027 (USD Million)
FIG. 54 Latin America in-vitro toxicology testing market, 2016 - 2027 (USD Million)
FIG. 55 Brazil in-vitro toxicology testing market, 2016 - 2027 (USD Million)
FIG. 56 Middle East & Africa in-vitro toxicology testing market, 2016 - 2027 (USD Million)
FIG. 57 South Africa in-vitro toxicology testing market, 2016 - 2027 (USD Million)
FIG. 58 Participant categorization
FIG. 59 Impact analysis by key companies
FIG. 60 Market position analysis for public companies
FIG. 61 Strategy framework"
The global in-vitro toxicology testing market size is anticipated to reach USD 30.9 billion by 2027 and is projected to register a CAGR of 9.2% over the forecast period, according to a new report by Grand View Research, Inc. The new paradigm shift in toxicity testing of animal models toward computational methods such as silico models to interpret toxicity pathway data, drives the demand for in-vitro toxicology testing. These methods provide cost and time efficiency and enhance safety assessment.
Several governments are taking measures to minimize animal-based test models, forming conducive government policies, and providing funds to support in-vitro models. These factors are expected to create ample growth opportunities for the market. For instance, in November 2019, the U.S. National Institute for Environmental Health Sciences planned to provide funds to small companies for the development of engineered 3D culture or organotypic culture models (OCM) in-vitro systems.
With advancements in high throughput screening, biological screening, and chemical synthesis, the number of publicly available databases containing data related to toxicity; absorption, distribution, metabolism, and excretion (ADME); pharmacovigilance; and drug screening has expanded rapidly. This has enabled scientists to access vast information for toxicity profiling, thereby spurring revenue generation in this market.
Abbott, Thermo Fisher, Agilent Technologies, GE Healthcare, Bio-Rad, and Merck KGaA are some of the key players operating in the market.
